These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36037658)

  • 1. miR-574, miR-499, miR-125b, miR-106a, and miR-9 potentially target TGFBR-1 and TGFBR-2 genes involving in inflammatory response pathway: Potential novel biomarkers for chronic lymphocytic leukemia.
    Hadi N; Namazi F; Ketabchi F; Khosravian F; Nateghi B; Talebi A; Baghi M; Mianesaz H; Zare F; Salehi M
    Pathol Res Pract; 2022 Oct; 238():154077. PubMed ID: 36037658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA profile at diagnosis predicts treatment outcome in patients with B-chronic lymphocytic leukemia: A FILO study.
    Duroux-Richard I; Gagez AL; Alaterre E; Letestu R; Khalifa O; Jorgensen C; Leprêtre S; Tchernonog E; Moreaux J; Cartron G; Apparailly F
    Front Immunol; 2022; 13():983771. PubMed ID: 36325355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression profile of miR-32, miR-98 and miR-374 in chronic lymphocytic leukemia.
    Rahimi Z; Ghorbani Z; Motamed H; Jalilian N
    Leuk Res; 2021 Dec; 111():106691. PubMed ID: 34455196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of MiR-125a as a Novel Plasma Diagnostic Biomarker for Chronic Lymphoblastic Leukemia.
    Ahmadvand M; Eskandari M; Khakpour G; Pashaiefar H; Manoochehrabadi S; Yaghmaie M; Montazer-Zohour M; Naghavi A
    Clin Lab; 2019 Mar; 65(3):. PubMed ID: 30868841
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential Expression Profile of miR-27b, miR-29a, and miR-155 in Chronic Lymphocytic Leukemia and Breast Cancer Patients.
    Raeisi F; Mahmoudi E; Dehghani-Samani M; Hosseini SSE; Ghahfarrokhi AM; Arshi A; Forghanparast K; Ghazanfari S
    Mol Ther Oncolytics; 2020 Mar; 16():230-237. PubMed ID: 32123723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations.
    Li Y; Mao M; Liu H; Wang X; Kou Z; Nie Y; Wang Y; Wang Z; Huang Q; Lang T; Gu Z; An L; Zhang X; Fu L
    Mol Cell Probes; 2019 Oct; 47():101436. PubMed ID: 31425738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of The Correlation between miR-106a, miR-125b, and miR-330 on Multiple Sclerosis Patients by Targeting TNFSF4 and SP1 in NF-кb/TNF-α Pathway: A Case-Control Study.
    Hadi N; Seifati SM; Nateghi B; Ravaghi P; Khosravian F; Namazi F; Fotouhi Firouzabad M; Shaygannejad V; Salehi M
    Cell J; 2022 Jul; 24(7):403-409. PubMed ID: 36043408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in The Plasma Expression of mir-15b, mir-195 and the Tumor-Suppressor Gene DLEU7 in Patients with B-Cell Chronic Lymphocytic Leukemia.
    Bagheri M; Khansarinejad B; Mosayebi G; Moradabadi A; Mondanizadeh M
    Rep Biochem Mol Biol; 2021 Apr; 10(1):20-29. PubMed ID: 34277865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia.
    Fathullahzadeh S; Mirzaei H; Honardoost MA; Sahebkar A; Salehi M
    Cancer Gene Ther; 2016 Oct; 23(10):327-332. PubMed ID: 27659777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia.
    Braga TV; Evangelista FCG; Gomes LC; Araújo SSDS; Carvalho MDG; Sabino AP
    Biomed Pharmacother; 2017 Aug; 92():864-869. PubMed ID: 28599250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
    Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
    Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state.
    Tili E; Michaille JJ; Luo Z; Volinia S; Rassenti LZ; Kipps TJ; Croce CM
    Blood; 2012 Sep; 120(13):2631-8. PubMed ID: 22723551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-20b, miR-98, miR-125b-1*, and let-7e* as new potential diagnostic biomarkers in ulcerative colitis.
    Coskun M; Bjerrum JT; Seidelin JB; Troelsen JT; Olsen J; Nielsen OH
    World J Gastroenterol; 2013 Jul; 19(27):4289-99. PubMed ID: 23885139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.
    Zhu DX; Miao KR; Fang C; Fan L; Zhu W; Zhu HY; Zhuang Y; Hong M; Liu P; Xu W; Li JY
    Leuk Res; 2011 Jun; 35(6):730-4. PubMed ID: 21130495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia.
    Mirzaei H; Fathullahzadeh S; Khanmohammadi R; Darijani M; Momeni F; Masoudifar A; Goodarzi M; Mardanshah O; Stenvang J; Jaafari MR; Mirzaei HR
    J Cell Physiol; 2018 Feb; 233(2):888-900. PubMed ID: 28084621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-92a-3p overexpression in peripheral blood mononuclear cells is an independent predictor of prolonged overall survival of patients with chronic lymphocytic leukemia.
    Papageorgiou SG; Diamantopoulos MA; Kontos CK; Bouchla A; Vasilatou D; Bazani E; Scorilas A; Pappa V
    Leuk Lymphoma; 2019 Mar; 60(3):658-667. PubMed ID: 29911923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
    Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
    Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated miR-20b-5p expression in peripheral blood mononuclear cells: A novel, independent molecular biomarker of favorable prognosis in chronic lymphocytic leukemia.
    Papageorgiou SG; Kontos CK; Tsiakanikas P; Stavroulaki G; Bouchla A; Vasilatou D; Bazani E; Lazarakou A; Scorilas A; Pappa V
    Leuk Res; 2018 Jul; 70():1-7. PubMed ID: 29715621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
    Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
    Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of altered expression of
    Shirmohammadi K; Sohrabi S; Jafarzadeh Samani Z; Effatpanah H; Yadegarazari R; Saidijam M
    J Gastrointest Oncol; 2018 Feb; 9(1):46-51. PubMed ID: 29564170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.